Gregory Glenn Zipp

Title: Gregory Glenn Zipp: Innovator in Pharmaceutical Compounds

Introduction

Gregory Glenn Zipp is a notable inventor based in Robbinsville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases and disorders.

Latest Patents

Zipp holds 2 patents that focus on innovative compounds. His latest patents include "Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use." This patent discloses compounds of the formula where R, R, and R are defined, along with compositions and methods for treating diseases mediated by adaptor associated kinase 1 activity. Another significant patent is for "Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use." Similar to the first, this patent outlines compounds of a specific formula and their applications in managing diseases related to adaptor associated kinase 1 activity.

Career Highlights

Gregory Zipp is currently associated with Lexicon Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options that can significantly impact patient care.

Collaborations

Zipp collaborates with talented individuals in his field, including Yingzhi Bi and Kenneth Gordon Carson. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Gregory Glenn Zipp is a prominent inventor whose work in pharmaceutical compounds is paving the way for new treatments. His patents reflect a commitment to addressing complex medical challenges through innovative solutions.